La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Andlauer Healthcare Group Résultats passés
Passé contrôle des critères 2/6
Andlauer Healthcare Group has been growing earnings at an average annual rate of 18.9%, while the Healthcare industry saw earnings growing at 15% annually. Revenues have been growing at an average rate of 21.2% per year. Andlauer Healthcare Group's return on equity is 16%, and it has net margins of 10%.
Informations clés
18.9%
Taux de croissance des bénéfices
15.4%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | -6.7% |
| Taux de croissance des recettes | 21.2% |
| Rendement des fonds propres | 16.0% |
| Marge nette | 10.0% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly
May 23
These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well
Jan 30Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing
Aug 24Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings
May 05Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?
Apr 07A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)
Dec 22Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns
Dec 09We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Oct 28These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely
Oct 12Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return
Aug 17We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Jul 19Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt
Jul 05The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing
May 04I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Apr 19Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?
Feb 23Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?
Jan 19We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger
Jan 06Should You Be Adding Andlauer Healthcare Group (TSE:AND) To Your Watchlist Today?
Dec 15Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?
Nov 17Returns On Capital Are Showing Encouraging Signs At Andlauer Healthcare Group (TSE:AND)
Sep 20Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 44% Undervaluation?
Sep 03Do Andlauer Healthcare Group's (TSE:AND) Earnings Warrant Your Attention?
Aug 12Ventilation des recettes et des dépenses
Comment Andlauer Healthcare Group gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 648 | 65 | 53 | 0 |
| 31 Mar 24 | 644 | 65 | 51 | 0 |
| 31 Dec 23 | 648 | 66 | 51 | 0 |
| 30 Sep 23 | 645 | 67 | 52 | 0 |
| 30 Jun 23 | 653 | 71 | 51 | 0 |
| 31 Mar 23 | 665 | 76 | 50 | 0 |
| 31 Dec 22 | 648 | 76 | 48 | 0 |
| 30 Sep 22 | 616 | 110 | 44 | 0 |
| 30 Jun 22 | 555 | 103 | 41 | 0 |
| 31 Mar 22 | 493 | 95 | 38 | 0 |
| 31 Dec 21 | 440 | 90 | 35 | 0 |
| 30 Sep 21 | 394 | 51 | 32 | 0 |
| 30 Jun 21 | 365 | 47 | 31 | 0 |
| 31 Mar 21 | 328 | 41 | 29 | 0 |
| 31 Dec 20 | 314 | 38 | 29 | 0 |
| 30 Sep 20 | 304 | 31 | 29 | 0 |
| 30 Jun 20 | 299 | 30 | 27 | 0 |
| 31 Mar 20 | 300 | 31 | 26 | 0 |
| 31 Dec 19 | 290 | 30 | 23 | 0 |
| 30 Sep 19 | 285 | 28 | 20 | 0 |
| 31 Dec 18 | 277 | 27 | 22 | 0 |
| 31 Dec 17 | 251 | 22 | 20 | 0 |
| 31 Dec 16 | 224 | 19 | 21 | 0 |
Des revenus de qualité: AND has high quality earnings.
Augmentation de la marge bénéficiaire: AND's current net profit margins (10%) are lower than last year (10.9%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: AND's earnings have grown by 18.9% per year over the past 5 years.
Accélération de la croissance: AND's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: AND had negative earnings growth (-9.2%) over the past year, making it difficult to compare to the Healthcare industry average (6%).
Rendement des fonds propres
ROE élevé: AND's Return on Equity (16%) is considered low.